InSysBio to take part in ACoP11

March 2017

9 1. 09 Mar 2017 14:10 ISBM Enclosed Conference was held 20-22 February 2017 the 10th ISBM Enclosed Conference was held. For ten years the employees annually have been meeting together to share their scientific results and talk over future plans. ISBM did a great job in this working year.

15 1. 15 Mar 2017 11:49 Institute for Systems Biology participates in American Society for Clinical Pharmacology and Therapeutics 2017 Meeting Institute for Systems Biology Moscow – a company, providing modeling services for innovative drug design, announced participation in ASCPT 2017 Meeting, which is held on 15-18 March in Washington, DC. ISBM will present several studies and demonstrate an updated version of platform for quantitative systems pharmacology modeling of immune response - Immune Response Template (IRT).

28 1. 28 Mar 2017 17:56 Not all therapies are effective: Institute for Systems Biology Moscow to present the results of the Alzheimer’s disease Systems Pharmacology Modeling Moscow, Russia – March 28, 2017. On the 1st April, Tatyana Karelina, ISBM leading specialist in neurodegenerative field, will present a poster entitled "Amyloid toxicity and different mechanisms of action for amyloid-targeted treatments studied by quantitative systems pharmacology model" at the 13th International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders to be held on March 29 - April 2, Vienna, Austria.

events

Conference

September 16, 2020

September 16, 2020

InSysBio announces its participation in Eleventh American Conference on Pharmacometrics (ACoP11) which is to be held in virtual format this year due to COVID-19 spread 9-13 November, 2020. The theme of ACoP11 is “Scaling New Heights.” InSysBio team is going to present 9 posters in frames of the Conference, namely:

Tuesday, November 10:

TUE-003 “Stimulation of erythropoiesis with ESA or blood donation: QSP model” by Alexander Stepanov, Galina Lebedeva
TUE-049 “Quantitative mechanistic model for amyloid beta and tau protein role in synaptic plasticity” by Stepan Lerner, Tatiana Karelina

Wednesday, November 11:

WED-027 “Application of different approaches to generate virtual patient populations for QSP model of Erythropoiesis” by Galina Kolesova, Oleg Demin, Alexander Stepanov
WED-034 “Practical Identifiability Analysis of QSP Models with LikelihoodProfiler” by Ivan Borisov, Evgeny Metelkin
WED-061 “Semi-mechanistic PK/RO modeling of anti-CD47 therapeutic agents” by Elena Vasileva1,2, Oleg Demin Jr2

Affiliation: 1 Lomonosov Moscow State University, Moscow, Russia; 2InSysBio, Moscow, Russia

Thursday, November 12:

THU-023 ““Heta compiler” is a framework for the development and management of Quantitative Systems Pharmacology modeling platforms” by Evgeny Metelkin
THU-078 “Monoclonal antibody therapy efficacy can be boosted by combinations with other treatments: predictions from integrated Alzheimer’s disease QSP platform” by Tatiana Karelina, Stepan Lerner
THU-082 “Unified approach for in vitro data based parameters estimation” by Veronika Musatova, Oleg Demin, Svetlana Rubina
THU-085 “CYTOCON as a tool to collect, compare and visualize available data on cells and cytokine concentrations in humans” by Vlad Leonov, Ekaterina Mogilevskaia, Elita Gerasimuk, Nail Gizzatkulov, Oleg Demin

We are looking forward to seeing again in person next year!

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

←	March 2017	→
Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9 1. 09 Mar 2017 14:10 ISBM Enclosed Conference was held 20-22 February 2017 the 10th ISBM Enclosed Conference was held. For ten years the employees annually have been meeting together to share their scientific results and talk over future plans. ISBM did a great job in this working year.	10	11	12
13	14	15 1. 15 Mar 2017 11:49 Institute for Systems Biology participates in American Society for Clinical Pharmacology and Therapeutics 2017 Meeting Institute for Systems Biology Moscow – a company, providing modeling services for innovative drug design, announced participation in ASCPT 2017 Meeting, which is held on 15-18 March in Washington, DC. ISBM will present several studies and demonstrate an updated version of platform for quantitative systems pharmacology modeling of immune response - Immune Response Template (IRT).	16	17	18	19
20	21	22	23	24	25	26
27	28 1. 28 Mar 2017 17:56 Not all therapies are effective: Institute for Systems Biology Moscow to present the results of the Alzheimer’s disease Systems Pharmacology Modeling Moscow, Russia – March 28, 2017. On the 1st April, Tatyana Karelina, ISBM leading specialist in neurodegenerative field, will present a poster entitled "Amyloid toxicity and different mechanisms of action for amyloid-targeted treatments studied by quantitative systems pharmacology model" at the 13th International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders to be held on March 29 - April 2, Vienna, Austria.	29	30	31

Upcoming Events

18.10

InSysBio to participate in ACoP 2025